March 2, 2021
Business News

Senseonics Holdings Announces $50.0 Million Registered Direct Offering of Common Stock


GERMANTOWN, Md.–()–Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it has entered into securities purchase agreements with several healthcare-focused and other institutional investors to purchase 40,000,000 shares of its common stock in a registered direct offering at a purchase price of $1.25 per share.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

The gross proceeds from the registered direct offering are expected to be $50.0 million before deducting placement agent fees and other…



Click here to view the original article.

Related Posts

You might also like ...

Tankfarm Hires Veteran Tech Investor as CFO
InSync Healthcare Solutions Awarded 2021 Top Workplace in Tampa Bay
Titan Medical to Present at H.C. Wainwright Global Life Sciences Conference